JANA ASHBURN: Open Payments
NPI 1912458027 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$835 in 33 payments from 12 companies in 2025. Trend: 2023 $737 · 2024 $760 · 2025 $835
Food & beverage: $835
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $184 |
| Otsuka America Pharmaceutical, Inc. | 7 | $153 |
| Amgen Inc. | 3 | $149 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $83 |
| Travere Therapeutics, Inc. | 3 | $77 |
| Calliditas Therapeutics US Inc. | 2 | $40 |
| Ardelyx, Inc. | 2 | $34 |
| ANI Pharmaceuticals, Inc. | 1 | $30 |
| Alexion Pharmaceuticals, Inc. | 1 | $24 |
| Novo Nordisk Inc | 1 | $22 |
Products named: Kerendia, JYNARQUE, KRYSTEXXA, JARDIANCE, TARPEYO, IBSRELA, PURIFIED CORTROPHIN GEL, ULTOMIRIS.
Industry payments across TX — which companies pay providers there.
